Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Oral fosfomycin efficacy with variable urinary exposures following single and multiple doses against Enterobacterales: the importance of heteroresistance on growth outcome.

Abbott IJ, van Gorp E, Wijma RA, Meletiadis J, Roberts JA, Mouton JW, Peleg AY.

Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01982-19. doi: 10.1128/AAC.01982-19. [Epub ahead of print]

PMID:
31907184
2.

Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.

Abbott IJ, Dekker J, van Gorp E, Wijma RA, Raaphorst MN, Klaassen CHW, Meletiadis J, Mouton JW, Peleg AY.

J Antimicrob Chemother. 2019 Dec 24. pii: dkz519. doi: 10.1093/jac/dkz519. [Epub ahead of print]

PMID:
31873748
3.

Epidemiological trends of fungemia in Greece with focus on candidemia during recent financial crisis: a 10-year survey in a tertiary care academic hospital and review of literature.

Siopi M, Tarpatzi A, Kalogeropoulou E, Damianidou S, Vasilakopoulou A, Vourli S, Pournaras S, Meletiadis J.

Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01516-19. doi: 10.1128/AAC.01516-19. [Epub ahead of print]

PMID:
31871083
4.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5. Review.

PMID:
31699664
5.

Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.

Beredaki MI, Georgiou PC, Siopi M, Kanioura L, Arendrup MC, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2020 Jan 1;75(1):140-148. doi: 10.1093/jac/dkz425.

PMID:
31665417
6.

Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.

Tavakoli M, Rivero-Menendez O, Abastabar M, Hedayati MT, Sabino R, Siopi M, Zarrinfar H, Nouripour-Sisakht S, van der Lee H, Valadan R, Meletiadis J, Yazdani Charati J, Seyedmousavi S, Alastruey-Izquierdo A.

Mycoses. 2020 Jan;63(1):78-88. doi: 10.1111/myc.13019. Epub 2019 Nov 3.

PMID:
31609022
7.

Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Meletiadis J, Siopi M, Kanioura L, Jørgensen KM, Perlin DS, Mouton JW, Arendrup MC.

J Antimicrob Chemother. 2019 Aug 1;74(8):2247-2254. doi: 10.1093/jac/dkz154.

PMID:
31106352
8.

Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision-authors' response.

Mouton JW, Meletiadis J, Voss A, Turnidge J.

J Antimicrob Chemother. 2019 Jun 1;74(6):1761-1762. doi: 10.1093/jac/dkz142. No abstract available.

PMID:
30989229
9.

In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.

Siopi M, Mouton JW, Pournaras S, Meletiadis J.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02673-18. doi: 10.1128/AAC.02673-18. Print 2019 Jun.

10.

Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model.

Gamaletsou MN, Meletiadis J, Chatziioannou S, Panayiotides IG, Agadakos E, Katsimpoulas M, Kostomitsopoulos N, Petraitis V, Walsh TJ, Sipsas NV.

Med Mycol. 2019 Nov 1;57(8):1011-1017. doi: 10.1093/mmy/myz001.

PMID:
30753591
11.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

12.

Erratum for Meletiadis et al., "Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone".

Meletiadis J, Turlej-Rogacka A, Lerner A, Adler A, Tacconelli E, Mouton JW.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02184-18. doi: 10.1128/AAC.02184-18. Print 2018 Dec. No abstract available.

13.

Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.

Tsala M, Vourli S, Georgiou PC, Pournaras S, Daikos GRL, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2019 Feb 1;74(2):387-394. doi: 10.1093/jac/dky422.

PMID:
30376071
14.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

15.

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.

Guinea J, Verweij PE, Meletiadis J, Mouton JW, Barchiesi F, Arendrup MC; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).

Clin Microbiol Infect. 2019 Jun;25(6):681-687. doi: 10.1016/j.cmi.2018.09.008. Epub 2018 Sep 28. Review.

PMID:
30268672
16.

An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics.

Otto RG, van Gorp E, Kloezen W, Meletiadis J, van den Berg S, Mouton JW.

Int J Antimicrob Agents. 2019 Jan;53(1):34-39. doi: 10.1016/j.ijantimicag.2018.09.003. Epub 2018 Sep 19.

PMID:
30240838
17.

Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision.

Mouton JW, Meletiadis J, Voss A, Turnidge J.

J Antimicrob Chemother. 2018 Sep 1;73(9):2374-2379. doi: 10.1093/jac/dky232.

PMID:
30137390
18.

Management of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations.

Sipsas NV, Pagoni MN, Kofteridis DP, Meletiadis J, Vrioni G, Papaioannou M, Antoniadou A, Petrikkos G, Samonis G.

J Fungi (Basel). 2018 Aug 9;4(3). pii: E94. doi: 10.3390/jof4030094.

19.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2018 Aug 1;73(8):2274. doi: 10.1093/jac/dky218. No abstract available.

PMID:
29800383
20.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

21.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method.

Arendrup MC, Meletiadis J, Zaragoza O, Jørgensen KM, Marcos-Zambrano LJ, Kanioura L, Cuenca-Estrella M, Mouton JW, Guinea J.

Clin Microbiol Infect. 2018 Nov;24(11):1200-1204. doi: 10.1016/j.cmi.2018.02.021. Epub 2018 Mar 2.

22.

A New Marker of Echinocandin Activity in an In Vitro Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus Infection.

Meletiadis J, Siopi M, Tsakris A, Mouton JW, Pournaras S.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02322-17. doi: 10.1128/AAC.02322-17. Print 2018 May.

23.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, Kidd S, Pelaez T, Sanguinetti M, Meletiadis J, Botterel F, Bustamante B, Chen YC, Chakrabarti A, Chowdhary A, Chryssanthou E, Córdoba S, Gonzalez GM, Guarro J, Johnson EM, Kus JV, Lass-Flörl C, Linares-Sicilia MJ, Martín-Mazuelos E, Negri CE, Pfaller MA, Tortorano AM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01916-17. doi: 10.1128/AAC.01916-17. Print 2018 Apr.

24.

Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints.

Tsala M, Vourli S, Georgiou PC, Pournaras S, Tsakris A, Daikos GL, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2018 Apr 1;73(4):953-961. doi: 10.1093/jac/dkx522.

PMID:
29377998
25.

Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.

Abbott IJ, Meletiadis J, Belghanch I, Wijma RA, Kanioura L, Roberts JA, Peleg AY, Mouton JW.

J Antimicrob Chemother. 2018 Mar 1;73(3):709-719. doi: 10.1093/jac/dkx441.

PMID:
29253153
26.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3325-3333. doi: 10.1093/jac/dkx319. Erratum in: J Antimicrob Chemother. 2018 Aug 1;73(8):2274.

PMID:
29029256
27.

Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae.

Fransen F, Hermans K, Melchers MJB, Lagarde CCM, Meletiadis J, Mouton JW.

J Antimicrob Chemother. 2017 Dec 1;72(12):3374-3381. doi: 10.1093/jac/dkx328.

PMID:
29029067
28.

Pharmacodynamics of nitrofurantoin at different pH levels against pathogens involved in urinary tract infections.

Fransen F, Melchers MJB, Lagarde CMC, Meletiadis J, Mouton JW.

J Antimicrob Chemother. 2017 Dec 1;72(12):3366-3373. doi: 10.1093/jac/dkx313.

PMID:
28961900
29.

Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.

Meletiadis J, Turlej-Rogacka A, Lerner A, Adler A, Tacconelli E, Mouton JW; the SATURN Diagnostic Study Group.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00473-17. doi: 10.1128/AAC.00473-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

30.

Fluconazole Pharmacokinetics in Galleria mellonella Larvae and Performance Evaluation of a Bioassay Compared to Liquid Chromatography-Tandem Mass Spectrometry for Hemolymph Specimens.

Astvad KMT, Meletiadis J, Whalley S, Arendrup MC.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00895-17. doi: 10.1128/AAC.00895-17. Print 2017 Oct.

31.

Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.

Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00485-17. doi: 10.1128/AAC.00485-17. Print 2017 Jun.

32.

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C.

Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.

33.

Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.

Siopi M, Pournaras S, Meletiadis J.

J Clin Microbiol. 2017 Jun;55(6):1714-1719. doi: 10.1128/JCM.00044-17. Epub 2017 Mar 22.

34.

In vitro combination therapy with isavuconazole against Candida spp.

Katragkou A, McCarthy M, Meletiadis J, Hussain K, Moradi PW, Strauss GE, Myint KL, Zaw MH, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ, Petraitis V.

Med Mycol. 2017 Nov 1;55(8):859-868. doi: 10.1093/mmy/myx006.

PMID:
28204571
35.

In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination.

Meletiadis J, Curfs-Breuker I, Meis JF, Mouton JW.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02372-16. doi: 10.1128/AAC.02372-16. Print 2017 Apr.

36.

Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Al-Hatmi AM, Normand AC, Ranque S, Piarroux R, de Hoog GS, Meletiadis J, Meis JF.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01671-16. doi: 10.1128/AAC.01671-16. Print 2017 Jan.

37.

Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.

Meletiadis J, Leth Mortensen K, Verweij PE, Mouton JW, Arendrup MC.

Clin Microbiol Infect. 2017 Feb;23(2):98-103. doi: 10.1016/j.cmi.2016.10.017. Epub 2016 Oct 25.

38.

Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae.

Tsala M, Vourli S, Daikos GL, Tsakris A, Zerva L, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2017 Jan;72(1):172-180. Epub 2016 Sep 19.

PMID:
27650184
39.

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin.

Mpakosi A, Siopi M, Falaina V, Siafakas N, Roilides E, Kimouli M, Theodoraki M, Karle P, Meletiadis J.

Med Mycol Case Rep. 2016 Aug 3;12:24-7. doi: 10.1016/j.mmcr.2016.08.002. eCollection 2016 Jun.

40.

Reply to "Agar Bioassays for Antifungals in Combination Therapy".

Siopi M, Meletiadis J.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5626. doi: 10.1128/AAC.00989-16. Print 2016 Sep. No abstract available.

41.
42.

Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods.

Meletiadis J, Geertsen E, Curfs-Breuker I, Meis JF, Mouton JW.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6173-8. doi: 10.1128/AAC.01027-16. Print 2016 Oct.

43.

Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infections.

Fransen F, Melchers MJ, Meletiadis J, Mouton JW.

J Antimicrob Chemother. 2016 Oct;71(10):2883-9. doi: 10.1093/jac/dkw212. Epub 2016 Jun 7.

PMID:
27278898
44.

Balanced control of both hyper and hypo-inflammatory phases as a new treatment paradigm in sepsis.

Tsirigotis P, Chondropoulos S, Gkirkas K, Meletiadis J, Dimopoulou I.

J Thorac Dis. 2016 May;8(5):E312-6. doi: 10.21037/jtd.2016.03.47.

45.

Comparison of Short Versus Prolonged Infusion of Standard Dose of Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae Isolates in Different Patient Groups: A Pharmacokinetic-Pharmacodynamic Approach.

Vourli S, Tsala M, Kotsakis S, Daikos GL, Tzouvelekis L, Miriagou V, Zerva L, Meletiadis J.

J Pharm Sci. 2016 Apr;105(4):1513-8. doi: 10.1016/j.xphs.2016.02.008.

PMID:
27019965
46.

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

Arendrup MC, Meletiadis J, Mouton JW, Guinea J, Cuenca-Estrella M, Lagrou K, Howard SJ; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).

Clin Microbiol Infect. 2016 Jun;22(6):571.e1-4. doi: 10.1016/j.cmi.2016.01.017. Epub 2016 Feb 3.

47.

In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.

Al-Hatmi AM, Meletiadis J, Curfs-Breuker I, Bonifaz A, Meis JF, De Hoog GS.

J Antimicrob Chemother. 2016 Apr;71(4):953-5. doi: 10.1093/jac/dkv421. Epub 2015 Dec 24.

PMID:
26702918
48.

Pharmacokinetic-pharmacodynamic modelling of meropenem against VIM-producing Klebsiella pneumoniae isolates: clinical implications.

Tsala M, Vourli S, Kotsakis S, Daikos GL, Tzouvelekis L, Zerva L, Miriagou V, Meletiadis J.

J Med Microbiol. 2016 Mar;65(3):211-218. doi: 10.1099/jmm.0.000214. Epub 2015 Dec 23.

PMID:
26697851
49.

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.

Ferro BE, Meletiadis J, Wattenberg M, de Jong A, van Soolingen D, Mouton JW, van Ingen J.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1097-105. doi: 10.1128/AAC.02615-15. Print 2016 Feb.

50.

Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins.

Siopi M, Neroutsos E, Zisaki K, Gamaletsou M, Pirounaki M, Tsirigotis P, Sipsas N, Dokoumetzidis A, Goussetis E, Zerva L, Valsami G, Meletiadis J.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):632-6. doi: 10.1128/AAC.01688-15. Print 2016 Jan.

Supplemental Content

Loading ...
Support Center